Varicella-zoster virus infection of a human CD4-positive T-cell line

Virology

Volumn 270, Issue 2, 2000, Pages 278-285

  Zerboni, Leigh ^a   Sommer, Marvin ^a   Ware, Carl F ^b   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GREEN FLUORESCENT PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; GENE EXPRESSION; HERPES ZOSTER; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VARICELLA ZOSTER VIRUS; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS TRANSMISSION;

CUCUMBER MOSAIC VIRUS; DNA VIRUSES; HERPES; HERPES ZOSTER; HERPESVIRIDAE; HUMAN HERPESVIRUS 3;

EID: 0034630846     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0304     Document Type: Article

References (29)

1. Arvin A. M. Varicella-zoster virus. Fields B. N., Knipe D. N., Howley P. M. Virology. 1996;2547-2585 Lippincott-Raven, Philadelphia.
2. Asano Y., Itakura N., Hiroishi Y., Hirose S., Nagai T., Ozaki T., Yazaki T., Yamanishi K., Takahashi M. Viremia is present in incubation period in nonimmunocompromised children with varicella. J. Pediatr. 106:1985;69-71.
3. Assouline J., Levin M., Major E., Forghani B., Straus S., Ostrove J. Varicella-zoster virus infection of human astrocytes, Schwann cells, and neurons. Virology. 179:1990;834-844.
4. Cohen J. I., Seidel K. E. Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc. Natl. Acad. Sci. USA. 90:1993;7376-7380.
5. Desai P., Person S. Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid. J. Virol. 72:1998;7563-7568.
6. Dumas A. M., Geelen J. L., Weststrate M. W., Wertheim P., van der Noordaa J. XbaI, PstI, and BglII restriction enzyme maps of the two orientations of the varicella-zoster virus genome. J. Virol. 39:1981;390-400.
7. Elliott G., O'Hare P. Live-cell analysis of a green fluorescent protein-tagged herpes simplex virus infection. J. Virol. 73:1999;4110-4119.
8. Fioretti A., Iwasaki Y., Furukawa T., Plotkin S. A., Kritchevsky D. The growth of varicella-zoster virus in guinea pig embryo cells. Proc. Soc. Exp. Biol. Med. 144:1973;340-344.
9. Foster T. P., Rybachuk G. V., Kousoulas K. G. Expression of the enhanced green fluorescent protein by herpes simplex virus type 1 (HSV-1) as an in vitro or in vivo marker for virus entry and replication. J. Virol. Methods. 75:1998;151-160.
10. Geder L., Vaczi L., Koller M. Persistent varicella and herpes simplex virus infection of a continuous monkey kidney cell culture. Acta Virol. 9:1965;431-436.
11. Grose C. Glycoproteins encoded by varicella-zoster virus: Biosynthesis, phosphorylation, and intracellular trafficking. Annu. Rev. Microbiol. 44:1990;59-80.
12. Koropchak C. M., Diaz P. S., Arvin A. M. Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization. J. Virol. 63:1989;2392-2395.
13. Koropchak C. M., Graham G., Palmer J., Winsberg M., Ting S. F., Wallace M., Prober C. G., Arvin A. M. Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella. J. Infect. Dis. 163:1991;1016-1022.
14. Mainka C., Fuss B., Geiger H., Hofelmayr H., Wolff M. H. Characterization of viremia at different stages of varicella-zoster virus infection. J. Med. Virol. 56:1998;91-98.
15. Mallory S., Sommer M., Arvin A. M. Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking. J. Virol. 71:1997;8279-8288.
16. Mauri D. N., Ebner R., Montgomery R. I., Kochel K. D., Cheung T. C., Yu G. L., Ruben S., Murphy M., Eisenberg R. J., Cohen G. H., Spear P. G., Ware C. F. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity. 8:1998;21-30.
17. Moffat J. F., Stein M. D., Kaneshima H., Arvin A. M. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 69:1995;5236-5242.
18. Moffat J. F., Zerboni L., Kinchington P. R., Grose C., Kaneshima H., Arvin A. M. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 72:1998;965-974.
19. Moffat J. F., Zerboni L., Sommer M. H., Heineman T. C., Cohen J. I., Kaneshima H., Arvin A. M. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc. Natl. Acad. Sci. USA. 95:1998;11969-11974.
20. Montgomery R. I., Warner M. S., Lum B. J., Spear P. G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell. 87:1996;427-436.
21. Myers M. G. Viremia caused by varicella-zoster virus: Association with malignant progressive varicella. J. Infect. Dis. 140:1979;229-233.
22. Perera L. P., Mosca J. D., Ruyechan W. T., Hay J. Regulation of varicella-zoster virus gene expression in human T lymphocytes. J. Virol. 66:1992;5298-5304.
23. Roizman B. Herpesviridae. Fields B. N., Knipe D. N., Howley P. M. Virology. 1996;2221-2230 Lippincott-Raven, Philadelphia.
24. Salio M., Cella M., Suter M., Lanzavecchia A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 29:1999;3245-3253.
25. Sawyer M. H., Wu Y. N., Chamberlin C. J., Burgos C., Brodine S. K., Bowler W. A., LaRocco A., Oldfield E. C., Wallace M. R. Detection of varicella-zoster virus DNA in the oropharynx and blood of patients with varicella. J. Infect. Dis. 166:1992;885-888.
26. Secchiero P., Berneman Z. N., Gallo R. C., Lusso P. Biological and molecular characteristics of human herpesvirus 7: In vitro growth optimization and development of a syncytia inhibition test. Virology. 202:1994;506-512.
27. Soong W., Schultz J. C., Patera A. C., Sommer M. H., Cohen J. I. Infection of human T lymphocytes with varicella-zoster virus: An analysis with viral mutants and clinical isolates. J. Virol. 74:2000;1864-1870.
28. Ware C. F., Crowe P. D., Grayson M. H., Androlewicz M. J., Browning J. L. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J. Immunol. 149:1992;3881-3888.
29. Ware C. F., Green L. M., Reade J., Stern M. L., Berger A. E. Human T cell hybridomas producing cytotoxic lymphokines: Induction of lymphotoxin release and killer cell activity by anti-CD3 monoclonal antibody or lectins and phorbol ester. Lymphokine Res. 5:1986;313-324.